VR Headsets in Cath Lab; ICDs & Driving Rules; How Cardiologist Got to Space

A look at the feasibility of coronary angiography and angioplasty procedures using the Meta Quest 3 virtual reality (VR) headset. (European Heart Journal)

FDA approved flurpiridaz F-18 (Flyrcado), a radiotracer for positron emission tomography myocardial perfusion imaging indicated for evaluation of myocardial ischemia and infarction in adults with known or suspected coronary artery disease.

The agency also gave clearance to the ShortCut leaflet modification device that facilitates valve-in-valve transcatheter aortic valve replacement in people at risk of coronary obstruction, Pi-Cardia announced.

Based on the BioImage study, people with subclinical atherosclerosis had an increased risk of death over a decade later, regardless of traditional cardiovascular risk factors. (Journal of the American College of Cardiology)

For coronary stenting in people with high bleeding risk, the ultrathin-strut biodegradable-polymer sirolimus-eluting Supraflex Cruz met noninferiority criteria in a randomized trial. (Circulation: Cardiovascular Interventions)

Sprinkling standalone chest pain units across densely populated areas may help with faster ECG access and percutaneous coronary intervention in low- and middle-income countries. (Lancet Regional Health-Southeast Asia)

How did a cardiologist get to go to space in August? (Space.com)

The Heart Rhythm Society put out a statement stressing that physicians who perform atrial fibrillation ablation must formally train and maintain skills in electrophysiology-based testing and mapping and advanced ablation therapeutics. (Heart Rhythm)

Clinical practice was affected by sex differences in prescription of and adherence to guideline-directed medical therapies after ischemic stroke. (Stroke)

Late gadolinium enhancement was a risk factor for sudden cardiac death in young people with hypertrophic cardiomyopathy. (JAMA Cardiology)

Current driving restrictions may not be in line with real-world motor vehicle crash risks after implantable cardioverter-defibrillator (ICD) implantation. (Heart)

Cereno Scientific announced that the investigational histone deacetylase inhibitor CS1 had promising phase IIa results in pulmonary arterial hypertension.

One observational analysis supports brief intermittent bursts of vigorous incidental physical activity to offset cardiovascular risks from a sedentary lifestyle. (European Journal of Preventive Cardiology)

In the PANORAMA-HF trial, sacubitril/valsartan (Entresto) was arguably no better than enalapril for treating pediatric patients with heart failure attributable to systemic left ventricular systolic dysfunction. (Circulation)

Low-dose spironolactone was frequently discontinued due to safety concerns in a randomized trial of patients with moderate stage chronic kidney disease. (Nature Medicine)

Differences in heart failure risks between Southeast and East Asian populations are arguably more pronounced than those between Black and white patients. (JAMA Network Open)

Getting heart transplant care at high-quality hospitals did not mitigate the excess risk of postoperative complications for socioeconomically disadvantaged people, suggesting contributions from persistent neighborhood deprivation. (Journal of Heart and Lung Transplantation)

Please enable JavaScript to view the

comments powered by Disqus.